Streetbeat News

Products Services

ITCI

Intra-Cellular Therapies will present results from two pivotal studies on lumateperone as an adjunctive therapy for major depressive disorder at the 2024 Psych Congress and NEI Congress.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

ACHR

Archer Aviation Inc. has signed an agreement with Soracle Corporation, a joint venture by Japan Airlines and Sumitomo Corporation, for the purchase of up to $500 million worth of electric aircraft. Soracle aims to introduce advanced air mobility services in Japan using Archer's Midnight aircraft.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

NRBO

NeuroBo Pharmaceuticals reported positive top-line data from its Phase 1 trial of DA-1726 for obesity, showing favorable safety and pharmacokinetics. The company has $21.7 million in cash, expected to fund operations into Q3 2025. Upcoming results include Phase 2a trial of DA-1241 for MASH in December 2024 and MAD Part 2 of DA-1726 in Q1 2025. A joint research agreement was entered with Dong-A ST and ImmunoForge for a long-acting formulation of DA-1726.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

MBLY

MIPS has launched the P8700 Series RISC-V Processor, the first high-performance AI-enabled CPU for automotive applications like ADAS and autonomous vehicles. This processor offers accelerated compute, power efficiency, and scalability.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

KAR

OPENLANE, Inc. (NYSE: KAR) will host a virtual Investor Update on November 19, 2024, at 10:00 a.m. The company is a leading operator of digital marketplaces for wholesale used vehicles.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

ALVO

Alvotech, a biotech company focused on biosimilar medicines, will participate in Citi's Global Healthcare Conference and Evercore's HealthCONx Conference in December 2024. The company will engage in one-on-one meetings and a fire-side chat.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

TCYSF

Atwoods Ranch & Home Goods has chosen Tecsys' OrderDynamics OMS to improve its omnichannel order fulfillment across over 75 retail outlets and its online store.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

JNJ

Johnson & Johnson is set to present 43 abstracts at the ACR 2024, highlighting its leadership in rheumatic disease innovation. Key presentations include data on investigational nipocalimab for Sjögren's Disease and TREMFYA® for psoriatic arthritis.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

INDP

Indaptus Therapeutics presented promising interim safety data from its Phase 1 clinical trial of Decoy20 at the SITC 2024 Annual Meeting. The data showed positive safety, pharmacokinetics, and biomarker results from two cohorts of single administration and one cohort of weekly administration.

Portfolio Pulse from

November 07, 2024 | 1:15 pm